Treatment of acute intermittent porphyria with adenosine-5-monophosphate: a long-term double-blind study.
D000227:Adenine Nucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011164:Porphyrias / Q000188:drug therapy*
D000227:Adenine Nucleotides; D010919:Placebos